•
Publications & Policy•
Publications•
Response to the European Commission Call for Evidence on the European Biotech Act
Positions & consultation responses
Invest Europe’s response highlights the need to close Europe’s biotech commercialization gap by accelerating time to market for breakthrough innovations, bridging the biotech investment gap, unlocking the potential of data, AI and quantum computing, and strengthening Europe’s entrepreneurial workforce.
EU venture capital programme a ‘great step forward’, says Invest Europe
Press releases
10 Apr 2018
Response to the European Commission Consultation on the EU life sciences strategy
Positions & consultation responses
16 Apr 2025
Position Paper on Investment Omnibus proposal
Positions & consultation responses
18 Mar 2025
Response to EC Consultation on General Block Exemption Rule
Positions & consultation responses
09 Dec 2021
Letter to the European Commission on public support to SMEs backed by private equity
Positions & consultation responses
01 Apr 2020
Position paper on EU response to the US Inflation Reduction Act
Positions & consultation responses
16 Mar 2023
Complementarity of EFSI and ESIF project financing
Member guides
01 Feb 2016
Accelerating innovation: Using public sector capital to attract private sector investors to the European venture capital industry
Member guides
09 Nov 2014
Guidelines on state aid to promote risk finance investments
Member guides
15 Jan 2014
MEMBER ONLY
Handbook on EU Funding
Member guides
07 Dec 2022
Finding the good answer: three questions for a better EU state aid framework
Opinion
17 Mar 2021
Response to the Commission’s targeted survey on simplifying the General Block Exemption Regulation (GBER)
Positions & consultation responses
02 Jul 2026